The following objectives across the end to end process of diagnostic development which will include:
• to hear updates from disease-specific subgroups and TPP production;
• to discuss progress made by the cross-cutting and resource mobilization subgroups;
• to discuss the ERPD NTD pilot and lessons learnt;
• to discuss advocacy and resource mobilization;
• to discuss engagement of manufacturers and developers; and
• to deliberate on the priority/focus areas of engagement for the DTAG for the coming years.
